key articles
Risk of death by age, sex, and smoking status in the United States
Thursday, 10 July 2008 - To make sense of the disease risks they face, people need basic facts about the magnitude of a particular risk and how one risk compares with other risks. Unfortunately, this fundamental information is...
Authors: Woloshin et al.
Family history of prostate cancer and prostate cancer
Thursday, 10 July 2008 - Prostate cancer family history has been associated with increased risk of the malignancy. Most prior studies have been retrospective and subject to recall bias, however, and data evaluating interactions...
Authors: Ahn et al.
Highly specific detection of prostate-specific antigen-positive cells in patients with prostate cancer or benign prostatic hyperplasia
Wednesday, 9 July 2008 - Barbero et al. (2008) assessed the presence of circulating prostate-specific antigen (PSA)-expressing cells in patients with prostate cancer or benign prostatic hyperplasia (BPH), and to determine their...
Authors: Barbero et al.
Statin Use and Risk of Prostate Cancer
Wednesday, 9 July 2008 - Epidemiologic studies of statin use in relation to prostate cancer risk have been inconclusive. Recent evidence, however, suggests that longer-term use may reduce risk of more advanced disease. Agalliu et...
Authors: Agalliu et al.
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men
Wednesday, 9 July 2008 - Overtreatment of prostate cancer (PCa) is a concern, especially in patients who might qualify for the diagnosis of insignificant prostate cancer (IPCa). Chun et al. (2008) tested the ability to identify...
Authors: Chun et al.
Tumor length in prostate cancer
Wednesday, 9 July 2008 - To evaluate the impact of tumor length and fraction of positive biopsy cores on overall survival, Vollmer (2008) used data for 526 patients with prostate cancer.
Median follow-up in patients not observed...
Authors: Vollmer
Effect of systemic nonhormonal management on prostate-cancer patients' survival and quality of life
Sunday, 6 July 2008 - Prostate cancer is a hormonal sensitive disease with a response rate ranging from 80 to 90%. However, the majority of patients develop hormone resistance resulting in poor long term survival....
Authors: Azim Jr. & Mok
Degarelix for prostate cancer
Saturday, 5 July 2008 - Degarelix is a gonadotropin-releasing hormone antagonist (GnRH receptor blocker) with immediate onset of action, suppressing gonadotropins, testosterone, and prostate-specific antigen (PSA) in prostate...
Authors: Van Poppel et al.
Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer
Saturday, 5 July 2008 - In a prospective study Bastide et al. (2008) assessed results and relevance of radioisotope guided pelvic lymph node dissection (PLND) in loco-regional staging in patients with clinically localized...
Authors: Bastide et al.
High-intensity focused ultrasound for locally radiorecurrent prostate cancer
Friday, 4 July 2008 - Local occurrence of prostate cancer (PCa) after external beam radiation (EBRT) may benefit from definitive local therapy Murat et al. (2008) evaluated the safety and efficacy of salvage high-intenstiy focal...
Authors: Murat et al.
